Anders William Ohman, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reperfusion Injury | 1 | 2021 | 1042 | 0.470 |
Why?
|
| Autophagy | 1 | 2021 | 1351 | 0.430 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 2329 | 0.310 |
Why?
|
| Liver | 2 | 2022 | 7562 | 0.270 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 4353 | 0.250 |
Why?
|
| Ovarian Neoplasms | 5 | 2023 | 4900 | 0.240 |
Why?
|
| Fallopian Tubes | 2 | 2023 | 178 | 0.210 |
Why?
|
| Cystadenocarcinoma, Serous | 2 | 2017 | 479 | 0.190 |
Why?
|
| Perfusion | 2 | 2022 | 1407 | 0.170 |
Why?
|
| Liver Transplantation | 2 | 2022 | 2412 | 0.170 |
Why?
|
| Organ Preservation | 1 | 2022 | 399 | 0.150 |
Why?
|
| Doxycycline | 1 | 2019 | 349 | 0.140 |
Why?
|
| 5-Methylcytosine | 1 | 2017 | 148 | 0.140 |
Why?
|
| Living Donors | 1 | 2021 | 645 | 0.140 |
Why?
|
| Phthalazines | 1 | 2018 | 397 | 0.130 |
Why?
|
| Peritoneal Neoplasms | 1 | 2018 | 703 | 0.100 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2013 | 326 | 0.090 |
Why?
|
| Genes, BRCA2 | 1 | 2013 | 588 | 0.090 |
Why?
|
| Genes, BRCA1 | 1 | 2013 | 750 | 0.080 |
Why?
|
| Ecology | 1 | 2009 | 105 | 0.080 |
Why?
|
| Piperazines | 1 | 2018 | 2549 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2018 | 1964 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2013 | 976 | 0.070 |
Why?
|
| Fungi | 1 | 2009 | 348 | 0.070 |
Why?
|
| Biodiversity | 1 | 2009 | 346 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 3819 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 2844 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2019 | 3785 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9525 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10429 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2018 | 1119 | 0.040 |
Why?
|
| Caspases | 1 | 2022 | 880 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2018 | 413 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13648 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 2014 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2017 | 354 | 0.030 |
Why?
|
| Mice | 5 | 2023 | 81819 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2018 | 2266 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1837 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 2018 | 800 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 2630 | 0.030 |
Why?
|
| Paired Box Transcription Factors | 1 | 2013 | 204 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 8611 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2013 | 711 | 0.020 |
Why?
|
| Integrases | 1 | 2013 | 520 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 6113 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2022 | 3081 | 0.020 |
Why?
|
| Animals | 5 | 2023 | 168764 | 0.020 |
Why?
|
| Proteomics | 1 | 2023 | 3910 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3608 | 0.020 |
Why?
|
| Epithelium | 1 | 2013 | 1599 | 0.020 |
Why?
|
| RNA, Fungal | 1 | 2009 | 156 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 2942 | 0.020 |
Why?
|
| Humans | 6 | 2023 | 765968 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 2009 | 441 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5747 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2822 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8529 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 4520 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 8501 | 0.020 |
Why?
|
| Species Specificity | 1 | 2009 | 2406 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2017 | 10070 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2017 | 4424 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2018 | 14448 | 0.010 |
Why?
|
| Female | 5 | 2023 | 396112 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13632 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9601 | 0.010 |
Why?
|
| Base Sequence | 1 | 2009 | 12403 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 4772 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18293 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29922 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 22332 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 223009 | 0.000 |
Why?
|